Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Erectile responses to DA-8159 in rabbit models

July 14, 2003

JNJ-10258859: a novel PDE5 inhibitor with potential in erectile dysfunction

July 14, 2003

Series of potassium channel modulators and their use reported by Wyeth

July 14, 2003

Use of dopamine D3 agonists in sexual dysfunction

July 11, 2003

Human arginase II: a possible target for the treatment of sexual arousal disorders

July 10, 2003

Muscarinic M2/M3 receptor antagonists for urinary incontinence and other uses

July 4, 2003

FDA accepts the NDA for trospium

July 4, 2003

Lilly Icos submits complete response to FDA for Cialis

July 4, 2003

Yamanouchi prepares and tests new vasopressin V2 ligands

June 25, 2003

Extended-release alfuzosin approved for BPH

June 18, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 27, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...